Esther Oh

  • Biography
  • Key Cases

Esther Oh specializes in class actions and other complex civil litigation, with a focus on antitrust. She enjoys working on complex litigation through the process of uncovering facts underneath the evidence presented, and then advocating those facts on behalf of disadvantaged purchasers and consumers.

Esther uses her knowledge of both information technology and legal processes to analyze clients’ electronically stored data to identify merits of claims, potential witnesses, and relevant facts and issues relative to litigation. She also conducts legal research and performs other duties to ensure that clients receive the best and most cost-effective legal solutions.

Prior to joining the Firm, Esther clerked for the Honorable Gerald Lebovits of the New York State Supreme Court and was a trial attorney at a boutique New York City law firm. Throughout law school, Esther was a judicial intern to the Honorable Richard Ringell, Karen Howze, Andrea Harnett, and Marisa Demeo of the Superior Court of the District of Columbia. She was also a student attorney at the Took Crowell Institute for At-Risk Youth Clinic in Washington, D.C.

Esther is a member of the American Bar Association and the Bar Association of San Francisco.

  • Capacitors Price-Fixing Antitrust Litigation: The Firm is Sole Lead Counsel in a class-action lawsuit alleging that global capacitor manufacturers conspired to fix prices, forcing direct purchasers to pay more. The class is certified and trial is proceeding in 2020. Initial settlements in the case total $343.5 million;
  • Generic Drug Price-Fixing Antitrust Litigation: The Firm is on the Plaintiffs’ Steering Committee representing U.S. consumers and insurers in a multi-district antitrust litigation accusing several generic drug manufacturers with conspiring to fix and raise prices for dozens of generic medications. In the past few years, prices for these drugs have skyrocketed by more than 1,000 percent. Consumers blame the companies for engineering these price hikes, eliminating the benefits of competition, and forcing them to pay exorbitant prices. The Firm is also currently investigating many other generic drugs for potential class action claims; and
  • Interior Molded Doors Litigation: The Firm is Interim Co-Lead Counsel for a proposed Indirect Purchaser Plaintiffs Class of individuals and companies who purchased interior molded doors from Defendants JELD-WEN, Inc. and Masonite Corporation. Plaintiffs allege that as a result of Defendants’ alleged anticompetitive conduct, Plaintiffs and other potential Class members paid more for doors than they would have in a competitive environment.